期刊文献+

静脉滴注尿激酶治疗急性心肌梗塞 被引量:2

Treatment of acute myocardial infarction by intra-venous infusion of urokinase
暂未订购
导出
摘要 为探讨静脉滴注尿激酶(UK)治疗急性心肌梗塞非创伤性的血流再通有效指标,观察溶栓治疗前后的心电图、血清酶及Rindex值等变化。结果:在UK大剂量组,maxST经静脉溶栓4h内下降率>50%,ΣST下降率>48%,Rindex值<10.9。经与文献对比研究,作者认为上述指标是判定血流再通的有效指标。另外,在急性心肌梗塞早期(梗塞6h内);大剂量UK(>90万U/d)经静脉给药后的冠状动脉再通率比中、小剂量较高。 In ofder to confirm the effect or non-invasive coronary reperfusion index(Rindex)on acute myocardial infarction by intravenous infusion of urokinase,the authorstudied the changes of ECG,serum enzyme and R indexbefore and after using thrombolytic therapy. the resultwas as follows :Max ST segment was lowered by morethan 50%,ΣST by more than 48%and R index wasless than 10.9 in the group with intravenous injection ofa large dose of urokinase. These data were effective criteria for assessing coronary blood fiow reperfusion. Besides. in the early stage(within 6 hrs. after onset) of acute myocardial infarction. a higher reperfusion rate wasseen when a large dose of intravenous urokinase( 90万U/day ) was given as compared with the use of small or medium dose of urokinase.
作者 宿清和
出处 《中国危重病急救医学》 CAS CSCD 1995年第2期81-84,共4页 Chinese Critical Care Medicine
关键词 心肌梗塞 急性 尿激酶 溶栓疗法 静脉 acute myocardial infarction:urokinase intravenous throbolytic therapy
  • 相关文献

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部